Premium
Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma
Author(s) -
Taube Adam,
Lundell Göran
Publication year - 1997
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/(sici)1097-0142(19970101)79:1<190::aid-cncr32>3.0.co;2-y
Subject(s) - medicine , thyroid carcinoma , logistic regression , ablation , randomized controlled trial , radioactive iodine , iodine , thyroid , radioiodine therapy , nuclear medicine , surgery , urology , materials science , metallurgy